233
Views
27
CrossRef citations to date
0
Altmetric
HYPOCRELLIN B-MEDIATED PDT ON CANCER CELLS

Effect of photodynamic therapy with hypocrellin B on apoptosis, adhesion, and migration of cancer cells

, , , &
Pages 575-579 | Received 03 Apr 2013, Accepted 13 Mar 2014, Published online: 23 Apr 2014

References

  • Ali SM, Chee SK, Yuen GY, Olivo M. 2001. Hypericin and hypocrellin induced apoptosis in human mucosal carcinoma cells. J Photochem Photobiol B 65:59–73.
  • Dougherty TJ, Gomer CJ, Henderson BW, Jori G, Kessel D, Korbelik M, Moan J, Peng Q. 1998. Photodynamic therapy. J Natl Cancer Inst 90:889–905.
  • Eckstein N. 2011. Platinum resistance in breast and ovarian cancer cell lines. J Exp Clin Cancer Res 30:91.
  • Hogberg T. 2010. Chemotherapy: Current drugs still have potential in advanced ovarian cancer. Nat Rev Clin Oncol 7:191–193.
  • Hudson JB, Zhou J, Chen J, Harris L, Yip L, Towers GH. 1994. Hypocrellin, from Hypocrella bambuase, is phototoxic to human immunodeficiency virus. Photochem Photobiol 60:253–255.
  • Hu L, McArthur C, Jaffe RB. 2010. Ovarian cancer stem-like side-population cells are tumourigenic and chemoresistant. Br J Cancer 102:1276–1283.
  • Hwang ES, Park KK. 2010. Magnolol suppresses metastasis via inhibition of invasion, migration, and matrix metalloproteinase-2/-9 activities in PC-3 human prostate carcinoma cells. Biosci Biotechnol Biochem 74:961–967.
  • Jäckel MC, Dorudian MA, Marx D, Brinck U, Schauer A, Steiner W. 1999. Spontaneous apoptosis in laryngeal squamous cell carcinoma is independent of bcl-2 and bax protein expression. Cancer 85:591–599.
  • Jiang Y, Leung AWN, Xiang JY, Xu CS. 2012a. Blue light-activated hypocrellin B damages ovarian cancer cells. Laser Phys 22:300–305.
  • Jiang Y, Xia X, Leung AW, Xiang J, Xu C. 2012b. Apoptosis of breast cancer cells induced by hypocrellin B under light-emitting diode irradiation. Photodiagnosis Photodyn Ther 9:337–343.
  • Jiang Y, Leung AW, Wang X, Zhang H, Xu C. 2013. Inactivation of Staphylococcus aureus by photodynamic action of hypocrellin B. Photodiagnosis Photodyn Ther 10:600–606.
  • LaMuraglia GM, Schiereck J, Heckenkamp J, Nigri G, Waterman P, Leszczynski D, Kossodo S. 2000. Photodynamic therapy induces apoptosis in intimal hyperplastic arteries. Am J Pathol 157:867–875.
  • Liu J, Zhao YW, Zhao JQ, Xia AD, Jiang LJ, Wu S, Ma L, Dong YQ, Gu YH. 2002. Two-photon excitation studies of hypocrellins for photodynamic therapy. J Photochem Photobiol B: Biol 68:156–164.
  • Liu Y, Wang X, Zhang B. 2008. Hypocrellin-based photodynamic sensitizers. Progress in Chem 20:1345–1352.
  • Ma G, Khan SI, Jacob MR, Tekwani BL, Li Z, Pasco DS, Walker LA, Khan IA. 2004. Antimicrobial and antileishmanial activities of hypocrellins A and B. Antimicrob Agents Chemother 48:4450–4452.
  • Ma L, Ta Hi, Li C, Zhang Y, Wang ZH, Ji WZ. 2003. Photodynamic inhibitory effects of three perylenequinones on human colorectal carcinoma cell line and primate embryonic stem cell line. World J Gastroenterol 9:485–490.
  • Shang L, Zhou N, Gu Y, Liu F, Zeng J. 2005. Comparative study on killing effect of esophageal cancer cell line between hypocrellin B-photodynamic therapy and hematoporphyrin derivative-photodynamic therapy. Chin J Cancer Prev Treat 12:1139–1142.
  • Varfolomeev E, Vucic D. 2011. Inhibitor of apoptosis proteins: Fascinating biology leads to attractive tumor therapeutic targets. Future Oncol 7:633–648.
  • Wang L, Ling Y, Chen Y, Li CL, Feng F, You QD, Lu N, Guo QL. 2010. Flavonoid baicalein suppresses adhesion migration and invasion of MDA-MB-231 human breast cancer cells. Cancer Lett 297:42–48.
  • Wang P, Xu CS, Xu J, Wang X, Leung AW. 2010. Hypocrellin B enhances ultrasound-induced cell death of nasopharyngeal carcinoma cells. Ultrasound Med Biol 36:336–342.
  • Wang X, Leung AW, Jiang Y, Yu H, Li X, Xu C. 2012. Hypocrellin B-mediated sonodynamic induces apoptosis of hepatocellular carcinoma cells. Ultrasonics 52:543–546.
  • Xu S, Chen S, Zhang M, Shen T. 2004. Hypocrellin derivative with improvements of red absorption and active oxygen species generation. Bioorg Med Chem Lett 14:1499–1501.
  • Yodkeeree S, Ampasavate C, Sung B, Aggarwal BB, Limtrakul P. 2010. Demethoxycurcumin suppresses migration and invasion of MDA-MB-231 human breast cancer cell line. Eur J Pharmacol 627:8–15.
  • Yu C, Xu S, Chen S, Zhang M, Shen T. 2002. Investigation of photobleaching of hypocrellin B in non-polar organic solvent and in liposome suspension. J Photochem Photobiol B 68: 73–78.
  • Yu J, Qian H, Li Y, Wang Y, Zhang X, Liang X, Fu M, Lin C. 2007. Arsenic trioxide (As2O3) reduces the invasive and metastatic properties of cervical cancer cells in vitro and in vivo. Gynecolog Oncol 106:400–406.
  • Yang CM, Liu YZ, Liao JW, Hu ML. 2010. The in vitro and in vivo anti-metastatic efficacy of oxythiamine and the possible mechanisms of action. Clin Exp Metastasis 27:341–349.
  • Zhao J, Deng H, Xie J, Huang N, Gu Y. 2010. Hypocrellin photosensitizers and photodynamic therapy to microvascular diseases. Acta Biophysica Sinica 26:1005–1014.
  • Zhou N, Shang L, Liu X. 2004. Comparative study on the killing effect between hypocrellin B-photodynamic therapy and hematoporphyrin derivative-photodynamic therapy on human lung cancer cells. Med J Chin PLA 29:1076–1078.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.